Test guide
Chromogenic Substrate Clotting Factor Assay
A reagent containing purified coagulation factors (FIXa, FX and thrombin) in optimal concentrations is added to test plasma in the first stage, which does not rely on the extrinsic or intrinsic initiation pathways as the thrombin activates FVIII. The amount of FXa generated in the first stage is measured by its action on a specific chromogenic substrate, which releases a chromophore upon cleavage. The color intensity produced is directly proportional to the amount of FXa, which in turn is directly proportional to the FVIII activity in the sample.
Key takeaways
A reagent containing purified coagulation factors (FIXa, FX and thrombin) in optimal concentrations is added to test plasma in the first stage, which does not rely on the extrinsic or intrinsic initiation pathways as the thrombin activates…
- Limitations: Terminology reference for a laboratory procedure. The source definition does not establish routine clinical availability, validated specimen types, reference…
- Intended audience: Laboratory professionals
- Last reviewed: 2026-11-20
What it is for
Source: National Cancer Institute, NCI Thesaurus 26.10d, C159552. Unmodified NCI definition, CC BY 4.0. Source identity and classification checked automatically on 2026-11-19.
Limitations
Terminology reference for a laboratory procedure. The source definition does not establish routine clinical availability, validated specimen types, reference intervals, product authorization or suitability for an individual. Consult the performing laboratory for its validated method and interpretation.
Also known as
- Chromogenic Substrate Assay
- Chromogenic Substrate Clotting Factor Assay
Reviewed products
Curated product links for this test are still under editorial review. Meanwhile, browse the product directory or request a supplier match below.
Review and references
Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.
2026-11-20
2026-11-20
professional use
FAQ
Common questions
What does the Chromogenic Substrate Clotting Factor Assay test measure?
A reagent containing purified coagulation factors (FIXa, FX and thrombin) in optimal concentrations is added to test plasma in the first stage, which does not rely on the extrinsic or intrinsic initiation pathways as the thrombin activates FVIII. The amount of FXa generated in the first stage is measured by its action on a specific chromogenic substrate, which releases a chromophore upon cleavage. The color intensity produced is directly proportional to the amount of FXa, which in turn is directly proportional to the FVIII activity in the sample.
How is the Chromogenic Substrate Clotting Factor Assay test performed?
Detection methods are not published on this record; confirm against the manufacturer’s instructions for use.
What sample types does the Chromogenic Substrate Clotting Factor Assay test use?
Sample types are not published on this record; confirm against the manufacturer’s instructions for use.
What are the limitations of the Chromogenic Substrate Clotting Factor Assay test?
Terminology reference for a laboratory procedure. The source definition does not establish routine clinical availability, validated specimen types, reference intervals, product authorization or suitability for an individual. Consult the…
